These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37220281)

  • 21. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil.
    Weber MB; Lorenzini D; Reinehr CP; Lovato B
    An Bras Dermatol; 2012; 87(5):697-702. PubMed ID: 23044560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peanut allergy impact on productivity and quality of life (PAPRIQUA): Caregiver-reported psychosocial impact of peanut allergy on children.
    Acaster S; Gallop K; de Vries J; Ryan R; Vereda A; Knibb RC
    Clin Exp Allergy; 2020 Nov; 50(11):1249-1257. PubMed ID: 32866989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients.
    Elbuluk N; Ezzedine K
    Dermatol Clin; 2017 Apr; 35(2):117-128. PubMed ID: 28317521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress in patients with alopecia areata and vitiligo.
    Manolache L; Benea V
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):921-8. PubMed ID: 17659001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silent celiac disease in dermatology.
    Real-Delor RE; Aldama-Negrete G; Aldama-Caballero A; Nunes-Tenace D; Aldama-Negrete F; Centurión-Medina I
    Rev Med Inst Mex Seguro Soc; 2020; 58(4):437-443. PubMed ID: 34543549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colocalization of vitiligo and alopecia areata presenting as poliosis.
    Walker A; Mesinkovska NA; Boncher J; Tamburro J; Bergfeld WF
    J Cutan Pathol; 2015 Feb; 42(2):150-4. PubMed ID: 25388912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study.
    Salman A; Yucelten AD; Sarac E; Saricam MH; Perdahli-Fis N
    An Bras Dermatol; 2018; 93(6):819-823. PubMed ID: 30484525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermatoglyphic patterns in psoriasis, vitiligo and alopecia areata.
    Kumar P; Gupta A
    Indian J Dermatol Venereol Leprol; 2010; 76(2):185-6. PubMed ID: 20228553
    [No Abstract]   [Full Text] [Related]  

  • 30. Quality of Life Impairment in Children and Adults with Vitiligo: A Cross-Sectional Study Based on Dermatology-Specific and Disease-Specific Quality of Life Instruments.
    Catucci Boza J; Giongo N; Machado P; Horn R; Fabbrin A; Cestari T
    Dermatology; 2016; 232(5):619-625. PubMed ID: 27603174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical Janus kinase inhibitors: A review of applications in dermatology.
    Hosking AM; Juhasz M; Mesinkovska NA
    J Am Acad Dermatol; 2018 Sep; 79(3):535-544. PubMed ID: 29673776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of the Excimer Laser: A Review.
    Beggs S; Short J; Rengifo-Pardo M; Ehrlich A
    Dermatol Surg; 2015 Nov; 41(11):1201-11. PubMed ID: 26458038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alopecia areata in childhood.
    Sahn EE
    Semin Dermatol; 1995 Mar; 14(1):9-14. PubMed ID: 7742246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy.
    Perche P; Purvis C; Pichardo R
    J Drugs Dermatol; 2022 Dec; 21(12):1366-1368. PubMed ID: 36468955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitiligo and alopecia areata: apples and oranges?
    Harris JE
    Exp Dermatol; 2013 Dec; 22(12):785-9. PubMed ID: 24131336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases.
    Manzoni AP; Pereira RL; Townsend RZ; Weber MB; Nagatomi AR; Cestari TF
    An Bras Dermatol; 2012; 87(3):361-8. PubMed ID: 22714749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.
    Zuo RC; Naik HB; Steinberg SM; Baird K; Mitchell SA; Kuzmina Z; Pavletic SZ; Cowen EW
    JAMA Dermatol; 2015 Jan; 151(1):23-32. PubMed ID: 25207994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
    Nasca MR; Micali G; Pulvirenti N; Licastro Cicero R
    Eur J Dermatol; 1998 Mar; 8(2):125-6. PubMed ID: 9649675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical profile and impact on quality of life: seven years experience with patients of alopecia areata.
    Al-Mutairi N; Eldin ON
    Indian J Dermatol Venereol Leprol; 2011; 77(4):489-93. PubMed ID: 21727697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.